| Literature DB >> 35455979 |
Richard Molnar1,2, Laszlo Szabo1,2, Andras Tomesz1,2, Arpad Deutsch1, Richard Darago1, Bence L Raposa1, Nowrasteh Ghodratollah2, Timea Varjas2, Balazs Nemeth2, Zsuzsanna Orsos2, Eva Pozsgai2, Jozsef L Szentpeteri3, Ferenc Budan3,4, Istvan Kiss2.
Abstract
Polyphenols are capable of decreasing cancer risk. We examined the chemopreventive effects of a green tea (Camellia sinensis) extract, polyphenol extract (a mixture of blackberry (Rubus fruticosus), blackcurrants (Ribes nigrum), and added resveratrol phytoalexin), Chinese bayberry (Myrica rubra) extract, and a coffee (Coffea arabica) extract on 7,12-dimethylbenz[a]anthracene (DMBA) carcinogen-increased miR-134, miR-132, miR-124-1, miR-9-3, and mTOR gene expressions in the liver, spleen, and kidneys of CBA/Ca mice. The elevation was quenched significantly in the organs, except for miR-132 in the liver of the Chinese bayberry extract-consuming group, and miR-132 in the kidneys of the polyphenol-fed group. In the coffee extract-consuming group, only miR-9-3 and mTOR decreased significantly in the liver; also, miR-134 decreased significantly in the spleen, and, additionally, miR-124-1 decreased significantly in the kidney. Our results are supported by literature data, particularly the DMBA generated ROS-induced inflammatory and proliferative signal transducers, such as TNF, IL1, IL6, and NF-κB; as well as oncogenes, namely RAS and MYC. The examined chemopreventive agents, besides the obvious antioxidant and anti-inflammatory effects, mainly blocked the mentioned DMBA-activated factors and the mitogen-activated protein kinase (MAPK) as well, and, at the same time, induced PTEN as well as SIRT tumor suppressor genes.Entities:
Keywords: 7,12-dimethylbenz[a]anthracene; carcinogen; coffee; mTOR; miR; miR-124-1; miR-132; miR-134; miR-9-3; polyphenol
Mesh:
Substances:
Year: 2022 PMID: 35455979 PMCID: PMC9029301 DOI: 10.3390/cells11081300
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 7.666
The details of the experimental arrangement and applied compounds.
| Group | Ip. | Daily Dose | Producer | Product and | Latin/Scientific Names | Quantity |
|---|---|---|---|---|---|---|
| - | ||||||
| + | ||||||
|
|
|
|
| |||
| Common grape vine seed, peel | 20 g/100 mL | |||||
| Erithritol | (2R,3S)-Butane-1,2,3,4-tetrol | 12 g/100 mL | ||||
| Resveratrol | 4 g/100 mL | |||||
| Blackberry ‘thornfree’ seed, peel | 2 g/100 mL | |||||
| Blackcurrant seed, peel |
| 2 g/100 mL | ||||
| Total polyphenol | 4000–5000 mg/100 mL | |||||
|
|
|
|
|
| ||
| Total polyphenol | 98.53% | |||||
| Total catechins | 80.42% | |||||
| EGCG | Epigallocatechin-3-gallate | 50.45% | ||||
| Caffeine | 1,3,7-Trimethylxanthine | 0.28% | ||||
|
|
|
|
| |||
| Chlorogenic acid | 3-Caffeoylquinic acid | 5.03% | ||||
| Caffeine | 1,3,7-Trimethylxanthine | 1.21% | ||||
|
|
|
|
|
| ||
| Myricetin | 3,5,7,3′,4′,5′-Hexahydroxyflavone | 80.42% |
Displays of the mTORC1 gene primer sequences (5′-3′), as well as miR-134, miR-132, miR-124-1, miR-9-3, and the internal control (mouse U6 gene).
| miR | Forward | Reverse |
|---|---|---|
| miR-134 | TGTGACTGGTTGACCAGAGG | GTGACTAGGTGGCCCACAG |
| miR-132 | ACCGTGGCTTTCGATTGTTA | CGACCATGGCTGTAGACTGTT |
| miR-124-1 | TCTCTCTCCGTGTTCACAGC | ACCGCGTGCCTTAATTGTAT |
| miR-9-3 | GCCCGTTTCTCTCTTTGGTT | TCTAGCTTTATGACGGCTCTGTGG |
| mTORC1 | AAGGCCTGATGGGATTTGG | TGTCAAGTACACGGGGCAAG |
| mouse U6 | CGCTTCGGCAGCACATATAC | TTCACGAATTTGCGTGTCAT |
Figure 1Expression patterns of miR-9-3, miR-124-1, miR-132, miR-134, and mTORC1 in the liver (A), spleen (B), and kidneys (C) of mice treated with DMBA and polyphenol extract (n = 6), compared to the DMBA-induced (n = 6) expression (* p < 0.05; *** p < 0.001).
Figure 2Expression patterns of miR-9-3, miR-124-1, miR-132, miR-134, and mTORC1 in the liver (A), spleen (B), and kidneys (C) of mice treated with DMBA and green tea extract (n = 6), compared to the DMBA-induced (n = 6) expression (* p < 0.05; *** p < 0.001).
Figure 3Expression patterns of miR-9-3, miR-124-1, miR-132, miR-134, and mTORC1 in the liver (A), spleen (B), and kidneys (C) of mice treated with DMBA and Chinese bayberry extract (n = 6), compared to the DMBA-induced (n = 6) expression (* p < 0.05; *** p < 0.001).
Figure 4Expression patterns of miR-9-3, miR-124-1, miR-132, miR-134, and mTORC1 in the liver (A), spleen (B), and kidneys (C) of mice treated with DMBA and coffee extract (n = 6), compared to the DMBA-induced (n = 6) expression (* p < 0.05).
Summary table of expression changes caused by feeding in the observed DMBA pretreated organs (* decreasing significantly p < 0.05; *** decreasing significantly p < 0.001; D decrease was not significant; O decrease was questionably; I increase was questionably).
| miR-9-3 | miR-124-1 | miR-132 | miR-134 | mTORC1 | |
|---|---|---|---|---|---|
|
| |||||
|
| * | *** | *** | *** | *** |
|
| * | * | *** | *** | *** |
|
| *** | * | D | *** | *** |
|
| |||||
|
| * | *** | * | *** | *** |
|
| *** | *** | *** | * | *** |
|
| * | * | *** | *** | *** |
|
| |||||
|
| *** | * | D | * | *** |
|
| * | * | * | *** | *** |
|
| * | * | *** | * | * |
|
| |||||
|
| * | O | O | O | * |
|
| * | O | I | * | * |
|
| * | * | I | * | * |
Figure 5Summary of the relevant factors influencing miRs and mTOR expression.